Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
J Psychopharmacol. 2019 Sep;33(9):1160-1169. doi: 10.1177/0269881119862533. Epub 2019 Aug 13.
Acute consumption of cannabis or its primary psychoactive ingredient ∆-tetrahydrocannabinol has been shown to impair memory, reaction time, time perception, and attention. However, it is difficult to measure these impairments in a brief test that can be used in a non-laboratory setting.
We aim to develop and validate a prototype for a mobile phone application to measure ∆-tetrahydrocannabinol-induced cognitive impairment.
We conducted two double-blind, within-subjects studies examining impairments after oral doses of ∆-tetrahydrocannabinol (0, 7.5, 15 mg) using both standardized computer-based tasks and our novel phone-based tasks. The tasks measured cognitive speed, reaction time, fine motor ability, and working memory and, in the second study, time perception. Study 1 (=24) provided initial data, and Study 2 (=24) was designed to refine the measures. In both studies, healthy non-daily cannabis users participated in three four-hour experimental sessions in which they received capsules containing ∆-tetrahydrocannabinol (7.5, 15 mg) or placebo. Subjective and cardiovascular measures were obtained at regular intervals, and at the time of peak drug effect subjects completed both standardized, computer-based and brief, phone-based tasks.
∆-Tetrahydrocannabinol-induced impairment was detected on most of the computer tasks, but was not evident on most of the phone tasks.
The phone tasks were brief, to facilitate use in a non-laboratory setting, but it is likely that this made them less sensitive to the impairing effects of ∆-tetrahydrocannabinol. These findings confirm that ∆-tetrahydrocannabinol impairs performance on several tasks at two recreationally relevant doses, but raises question about the feasibility of designing a phone application as a sensitive field sobriety test for cannabis.
急性摄入大麻或其主要精神活性成分 ∆-四氢大麻酚已被证明会损害记忆力、反应时间、时间感知和注意力。然而,在非实验室环境中使用的简短测试中,很难衡量这些损伤。
我们旨在开发和验证一种用于测量 ∆-四氢大麻酚引起的认知障碍的手机应用程序原型。
我们进行了两项双盲、自身对照研究,使用标准化的计算机任务和我们新的基于手机的任务,研究了口服 ∆-四氢大麻酚(0、7.5、15 毫克)后的损伤。这些任务测量认知速度、反应时间、精细运动能力和工作记忆,在第二项研究中还测量了时间感知。第一项研究(=24)提供了初步数据,第二项研究(=24)旨在改进测量方法。在两项研究中,健康的非习惯性大麻使用者参加了三个为期四小时的实验会议,在会议期间他们服用了含有 ∆-四氢大麻酚(7.5、15 毫克)或安慰剂的胶囊。定期获取主观和心血管测量值,在药物效果达到峰值时,受试者完成了标准化的计算机任务和简短的手机任务。
∆-四氢大麻酚引起的损伤在大多数计算机任务中都能检测到,但在大多数手机任务中都没有明显表现。
手机任务简短,便于在非实验室环境中使用,但这可能会降低它们对 ∆-四氢大麻酚损伤作用的敏感性。这些发现证实,在两个娱乐相关剂量下,∆-四氢大麻酚会损害多项任务的表现,但对设计一个手机应用程序作为大麻敏感现场清醒测试的可行性提出了疑问。